Literature DB >> 31541182

DAPK1 (death associated protein kinase 1) mediates mTORC1 activation and antiviral activities in CD8+ T cells.

Zhengping Wei1, Pingfei Li1,2, Ran He1, Huicheng Liu1, Na Liu1, Yu Xia1, Guoyu Bi1, Qiuyang Du1, Minghui Xia1, Lei Pei3,4, Jing Wang1, Guihua Wang5, Zhao-Hui Tang5, Xiang Cheng6, Huabin Li7, Zhuoya Li1, Lilin Ye8, Arian Laurence9, Youming Lu3,4, Xiang-Ping Yang10.   

Abstract

Mechanistic target of rapamycin complex 1 (mTORC1) regulates CD8+ T-cell differentiation and function. Despite the links between PI3K-AKT and mTORC1 activation in CD8+ T cells, the molecular mechanism underlying mTORC1 activation remains unclear. Here, we show that both the kinase activity and the death domain of DAPK1 are required for maximal mTOR activation and CD8+ T-cell function. We found that TCR-induced activation of calcineurin activates DAPK1, which subsequently interacts with TSC2 via its death domain and phosphorylates TSC2 to mediate mTORC1 activation. Furthermore, both the kinase domain and death domain of DAPK1 are required for CD8+ T-cell antiviral responses in an LCMV infection model. Together, our data reveal a novel mechanism of mTORC1 activation that mediates optimal CD8+ T-cell function and antiviral activity.

Entities:  

Keywords:  antiviral function; mTORC1; CD8+ T cells

Mesh:

Substances:

Year:  2019        PMID: 31541182      PMCID: PMC7852660          DOI: 10.1038/s41423-019-0293-2

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  44 in total

1.  mTORC1 and mTORC2 Kinase Signaling and Glucose Metabolism Drive Follicular Helper T Cell Differentiation.

Authors:  Hu Zeng; Sivan Cohen; Cliff Guy; Sharad Shrestha; Geoffrey Neale; Scott A Brown; Caryn Cloer; Rigel J Kishton; Xia Gao; Ben Youngblood; Mytrang Do; Ming O Li; Jason W Locasale; Jeffrey C Rathmell; Hongbo Chi
Journal:  Immunity       Date:  2016-09-13       Impact factor: 31.745

2.  The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment.

Authors:  Greg M Delgoffe; Thomas P Kole; Yan Zheng; Paul E Zarek; Krystal L Matthews; Bo Xiao; Paul F Worley; Sara C Kozma; Jonathan D Powell
Journal:  Immunity       Date:  2009-06-19       Impact factor: 31.745

3.  mTOR Signaling in Growth, Metabolism, and Disease.

Authors:  Robert A Saxton; David M Sabatini
Journal:  Cell       Date:  2017-04-06       Impact factor: 41.582

Review 4.  Regulation of immune responses by mTOR.

Authors:  Jonathan D Powell; Kristen N Pollizzi; Emily B Heikamp; Maureen R Horton
Journal:  Annu Rev Immunol       Date:  2011-11-29       Impact factor: 28.527

5.  The Kinase mTORC1 Promotes the Generation and Suppressive Function of Follicular Regulatory T Cells.

Authors:  Lifan Xu; Qizhao Huang; Haoqiang Wang; Yaxing Hao; Qiang Bai; Jianjun Hu; Yiding Li; Pengcheng Wang; Xiangyu Chen; Ran He; Bingshou Li; Xia Yang; Tingting Zhao; Yanyan Zhang; Yifei Wang; Juanjuan Ou; Houjie Liang; Yuzhang Wu; Xinyuan Zhou; Lilin Ye
Journal:  Immunity       Date:  2017-09-19       Impact factor: 31.745

Review 6.  Regulation and function of mTOR signalling in T cell fate decisions.

Authors:  Hongbo Chi
Journal:  Nat Rev Immunol       Date:  2012-04-20       Impact factor: 53.106

7.  The Interleukin-2-mTORc1 Kinase Axis Defines the Signaling, Differentiation, and Metabolism of T Helper 1 and Follicular B Helper T Cells.

Authors:  John P Ray; Matthew M Staron; Justin A Shyer; Ping-Chih Ho; Heather D Marshall; Simon M Gray; Brian J Laidlaw; Koichi Araki; Rafi Ahmed; Susan M Kaech; Joe Craft
Journal:  Immunity       Date:  2015-09-22       Impact factor: 31.745

8.  The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-bet and Eomesodermin.

Authors:  Rajesh R Rao; Qingsheng Li; Kunle Odunsi; Protul A Shrikant
Journal:  Immunity       Date:  2010-01-07       Impact factor: 31.745

9.  The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2.

Authors:  Greg M Delgoffe; Kristen N Pollizzi; Adam T Waickman; Emily Heikamp; David J Meyers; Maureen R Horton; Bo Xiao; Paul F Worley; Jonathan D Powell
Journal:  Nat Immunol       Date:  2011-02-27       Impact factor: 25.606

10.  mTORC1 couples immune signals and metabolic programming to establish T(reg)-cell function.

Authors:  Hu Zeng; Kai Yang; Caryn Cloer; Geoffrey Neale; Peter Vogel; Hongbo Chi
Journal:  Nature       Date:  2013-06-30       Impact factor: 49.962

View more
  3 in total

1.  Transcription factor EB coordinates environmental cues to regulate T regulatory cells' mitochondrial fitness and function.

Authors:  Minghui Xia; Cai Zhang; Yufei Chen; Xiujuan Zhao; Si Zhang; Yang Liu; You Cai; Zhengping Wei; Qiuyang Du; Wenting Yu; Chun Zhou; Hongjun Xiao; Guihua Wang; Xiang Cheng; Heng Mei; Arian Laurence; Jing Wang; Yu Hu; Huabin Li; Xiang-Ping Yang
Journal:  Proc Natl Acad Sci U S A       Date:  2022-07-27       Impact factor: 12.779

2.  Universal allogeneic CAR T cells engineered with Sleeping Beauty transposons and CRISPR-CAS9 for cancer immunotherapy.

Authors:  Jaitip Tipanee; Ermira Samara-Kuko; Thierry Gevaert; Marinee K Chuah; Thierry VandenDriessche
Journal:  Mol Ther       Date:  2022-06-16       Impact factor: 12.910

3.  Mucosal Vaccination with UV-Inactivated Chlamydia suis in Pre-Exposed Outbred Pigs Decreases Pathogen Load and Induces CD4 T-Cell Maturation into IFN-γ+ Effector Memory Cells.

Authors:  Amanda F Amaral; Khondaker S Rahman; Andrew R Kick; Lizette M Cortes; James Robertson; Bernhard Kaltenboeck; Volker Gerdts; Catherine M O'Connell; Taylor B Poston; Xiaojing Zheng; Chuwen Liu; Sam Y Omesi; Toni Darville; Tobias Käser
Journal:  Vaccines (Basel)       Date:  2020-07-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.